Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia.
Ruan GT, Deng L, Xie HL, Shi JY, Liu XY, Zheng X, Chen Y, Lin SQ, Zhang HY, Liu CA, Ge YZ, Song MM, Hu CL, Zhang XW, Yang M, Hu W, Cong MH, Zhu LC, Wang KH, Shi HP.
Ruan GT, et al.
Cancer Metab. 2024 Jan 25;12(1):3. doi: 10.1186/s40170-024-00332-8.
Cancer Metab. 2024.
PMID: 38273418
Free PMC article.